Pathophysiology and Treatment of Obesity Hypertension

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|29|3621-3637

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.29, 2004-11, pp. : 3621-3637

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence

By Provencher Steeve   Sitbon Olivier   Simonneau Gérald  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 8, 2005-07 ,pp. : 1337-1348

Informa Healthcare

Access to resources Recommend Favorite

Obesity: Pathophysiology and Clinical Management

By  

Current Medicinal Chemistry, Vol. 16, Iss. 4, 2009-02 ,pp. : 506-521

Bentham Science Publishers

Access to resources Recommend Favorite

Essential Hypertension: Translating Pathophysiology into Pharmacogenomics

By  

Current Pharmacogenomics, Vol. 4, Iss. 3, 2006-09 ,pp. : 219-229

Bentham Science Publishers

Access to resources Recommend Favorite

Hypertension in Pregnancy: Pathophysiology & Management Strategies

By  

Current Pharmaceutical Design, Vol. 13, Iss. 25, 2007-09 ,pp. : 2567-2579

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Clinical Management and Treatment of Hypertension, Its Pathophysiology and the Clinical Use of Antihypertensive Drugs (Executive Editor: Gregory Y.H. Lip)]

By  

Current Pharmaceutical Design, Vol. 12, Iss. 13, 2006-05 ,pp. : 1555-1555

Bentham Science Publishers

Access to resources Recommend Favorite